Advertisement

  • Patient Advocates Tune in for Precision Medicine Primer

    Scientists and physicians discussed advances in targeted therapies and immunotherapies, as well as the lessons COVID-19 research has taught to cancer researchers.

    by Kevin McLaughlin

  • Immunotherapy Options for Breast Cancer

    Two immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions.

    by Anna Goshua

  • Living Beyond a Diagnosis

    Judy Pearson was surprised by the demands of cancer survivorship. Here, she offers tips on how to look at life after cancer.

    by Judy Pearson

  • Q&A

    Ethics in Practice

    Rebecca Dresser explores the history and burdens of clinical trials through the lens of a cancer survivor and medical ethicist.

    by Marci A. Landsmann

  • Policy Matters

    Cancer Scientists Support COVID-19 Response

    Researchers study ways to improve telehealth capabilities, clinical trials and health disparities.

    by Trevan Locke, PhD

  • Physicians Underestimate Severity of Radiation Side Effects

    Breast cancer patients’ symptoms after radiation therapy may go underrecognized, especially if these patients are Black or younger in age.

    by Marci A. Landsmann

  • Taking Drug Dosing Off Autopilot

    Patient advocates with metastatic breast cancer argue that dosing of treatments for their disease should be more personalized and take into account quality of life.

    by Marcus A. Banks

  • Reasons to Hope During the COVID-19 Pandemic

    Patient advocates learned about COVID-19 and cancer in an AACR virtual forum.

    by Kevin McLaughlin

  • From the Editor-in-Chief

    Cancer in Minority Populations

    Paying attention to the social determinants of health will promote greater equity in cancer outcomes for all.

    by William G. Nelson, MD, PhD

  • Survivor Profile

    An Unlikely Pivot

    Medha Deoras-Sutliff’s experience with breast cancer fueled her interest in advocacy for breast cancer patients and, more recently, her support for research on rare cancers.

    by Lindsey Konkel

Advertisement
Advertisement

From the AACR

  • Prioritizing Vaccination

    The AACR led a contingent of 130 organizations in asking that cancer patients and survivors be granted high priority in receiving COVID-19 vaccinations.

  • Bolstering Diversity

    Eliminating disparities requires consistent effort on numerous fronts, including the development and sustenance of a diverse scientific workforce.

  • Screening During the Pandemic

    In March of last year, screenings for breast, colon and cervical cancer decreased by roughly 90% compared with historical rates.

Advertisement

Video

Learning Medicare’s ABCDs

Advertisement

social media

donate to the AACR